Refapentine, the first new anti-TB drug on the global healtcare horizon after 30 years, was recently approved by the US Food and Drug Administration (FDA) for pulmonary tuberculosis.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/hoechst-marion-launch-latest-anti-tb-drug-india
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/financial-express-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health